Viewing Study NCT05544227



Ignite Creation Date: 2024-05-06 @ 6:06 PM
Last Modification Date: 2024-10-26 @ 2:41 PM
Study NCT ID: NCT05544227
Status: ACTIVE_NOT_RECRUITING
Last Update Posted: 2024-04-04
First Post: 2022-08-16

Brief Title: Phase 1 Trial of SYNC-T - Immunotherapy for AdvancedMetastatic Castration-Resistant Prostate Cancer
Sponsor: Williams Cancer Foundation
Organization: Williams Cancer Foundation

Study Overview

Official Title: Immunotherapy Regimen Given After Targeted Local Cryolysis TLC for Patients With AdvancedMetastatic Castration-resistant Prostate Cancer mCRPC OR Those With Metastatic Prostate Cancer Who Refused Hormone Therapy and Chemotherapy
Status: ACTIVE_NOT_RECRUITING
Status Verified Date: 2024-04
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: SV-102 is intended to overcome the complex and multifactorial nature of the mechanisms mediating tumor immune evasion by the use of a combination of therapeutic agents that elicit multiple immuno-pharmacologic effects
Detailed Description: SV-102 is intended for immunotherapeutic treatment of solid tumors in certain metastatic cancer indications SYNC-T technology encompasses methods and compositions that mediate multiple pharmacologic effects aimed at mounting a synchronized and multi-faceted antitumor immune response The first component of SYNC-T is aimed at eliciting in situ immunization by triggering the lysis and immunogenic cell death of tumor cells followed by the release of tumor-specific or tumor-associated antigens TSATAAs and danger associated molecular patterns DAMPs into the tumor microenvironment The main approach that will be used by SYNC-T will rely on partial and targeted local cryolysis of tumor cells mediated by a cryolysis device The second component of SYNC-T technology is the intratumoral infusion of a low-dose multi-component drug product

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None